These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 11377437

  • 1. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study.
    Zobel AW, Nickel T, Sonntag A, Uhr M, Holsboer F, Ising M.
    J Psychiatr Res; 2001; 35(2):83-94. PubMed ID: 11377437
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of a salivary based combined dexamethasone/CRH test in patients with major depression.
    Baghai TC, Schüle C, Zwanzger P, Minov C, Holme C, Padberg F, Bidlingmaier M, Strasburger CJ, Rupprecht R.
    Psychoneuroendocrinology; 2002 Apr; 27(3):385-99. PubMed ID: 11818173
    [Abstract] [Full Text] [Related]

  • 3. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?
    Ising M, Horstmann S, Kloiber S, Lucae S, Binder EB, Kern N, Künzel HE, Pfennig A, Uhr M, Holsboer F.
    Biol Psychiatry; 2007 Jul 01; 62(1):47-54. PubMed ID: 17123470
    [Abstract] [Full Text] [Related]

  • 4. Association between response to lithium augmentation and the combined DEX/CRH test in major depressive disorder.
    Bschor T, Baethge C, Adli M, Eichmann U, Ising M, Uhr M, Modell S, Künzel H, Müller-Oerlinghausen B, Bauer M.
    J Psychiatr Res; 2003 Jul 01; 37(2):135-43. PubMed ID: 12842167
    [Abstract] [Full Text] [Related]

  • 5. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K.
    Psychoneuroendocrinology; 2008 Feb 01; 33(2):152-61. PubMed ID: 18068306
    [Abstract] [Full Text] [Related]

  • 6. Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression).
    Appelhof BC, Huyser J, Verweij M, Brouwer JP, van Dyck R, Fliers E, Hoogendijk WJ, Tijssen JG, Wiersinga WM, Schene AH.
    Biol Psychiatry; 2006 Apr 15; 59(8):696-701. PubMed ID: 16368077
    [Abstract] [Full Text] [Related]

  • 7. The combined dexamethasone/CRH Test (DEX/CRH test) and prediction of acute treatment response in major depression.
    Schüle C, Baghai TC, Eser D, Häfner S, Born C, Herrmann S, Rupprecht R.
    PLoS One; 2009 Apr 15; 4(1):e4324. PubMed ID: 19177168
    [Abstract] [Full Text] [Related]

  • 8. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients.
    Schüle C, Baghai TC, Eser D, Zwanzger P, Jordan M, Buechs R, Rupprecht R.
    Psychopharmacology (Berl); 2006 Jul 15; 186(4):601-11. PubMed ID: 16758243
    [Abstract] [Full Text] [Related]

  • 9. The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness.
    Rybakowski JK, Twardowska K.
    J Psychiatr Res; 1999 Jul 15; 33(5):363-70. PubMed ID: 10504004
    [Abstract] [Full Text] [Related]

  • 10. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB, Künzel HE, Nickel T, Kern N, Pfennig A, Majer M, Uhr M, Ising M, Holsboer F.
    Psychoneuroendocrinology; 2009 Jan 15; 34(1):99-109. PubMed ID: 18829172
    [Abstract] [Full Text] [Related]

  • 11. Lithium monotherapy increases ACTH and cortisol response in the DEX/CRH test in unipolar depressed subjects. A study with 30 treatment-naive patients.
    Bschor T, Ritter D, Winkelmann P, Erbe S, Uhr M, Ising M, Lewitzka U.
    PLoS One; 2011 Jan 15; 6(11):e27613. PubMed ID: 22132117
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.
    Künzel HE, Binder EB, Nickel T, Ising M, Fuchs B, Majer M, Pfennig A, Ernst G, Kern N, Schmid DA, Uhr M, Holsboer F, Modell S.
    Neuropsychopharmacology; 2003 Dec 15; 28(12):2169-78. PubMed ID: 12931142
    [Abstract] [Full Text] [Related]

  • 13. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
    Sher L, Oquendo MA, Burke AK, Cooper TB, Mann JJ.
    J Affect Disord; 2013 Dec 15; 151(3):1108-12. PubMed ID: 23866302
    [Abstract] [Full Text] [Related]

  • 14. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder.
    Watson S, Gallagher P, Ritchie JC, Ferrier IN, Young AH.
    Br J Psychiatry; 2004 Jun 15; 184():496-502. PubMed ID: 15172943
    [Abstract] [Full Text] [Related]

  • 15. Time-dependent effects of dexamethasone plasma concentrations on glucocorticoid receptor challenge tests.
    Menke A, Arloth J, Best J, Namendorf C, Gerlach T, Czamara D, Lucae S, Dunlop BW, Crowe TM, Garlow SJ, Nemeroff CB, Ritchie JC, Craighead WE, Mayberg HS, Rex-Haffner M, Binder EB, Uhr M.
    Psychoneuroendocrinology; 2016 Jul 15; 69():161-71. PubMed ID: 27107207
    [Abstract] [Full Text] [Related]

  • 16. Can the DEX/CRH test or markers of oxidative stress distinguish work-related stress from major depressive disorder and normal controls?
    Rotvig DH, Jorgensen A, Jensen JH, Hansen AR, Eller NH, Jonsson SH, Knorr U, Klose MC, Feldt-Rasmussen U, Menke A, Poulsen HE, Bauer JØ, Jørgensen MB.
    Stress; 2024 Jan 15; 27(1):2353781. PubMed ID: 38823417
    [Abstract] [Full Text] [Related]

  • 17. Sleep deprivation and hypothalamic-pituitary-adrenal (HPA) axis activity in depressed patients.
    Schüle C, Baghai T, Zwanzger P, Minov C, Padberg F, Rupprecht R.
    J Psychiatr Res; 2001 Jan 15; 35(4):239-47. PubMed ID: 11578642
    [Abstract] [Full Text] [Related]

  • 18. Cortisol response patterns in depressed women and their healthy daughters at risk: Comparison with healthy women and their daughters.
    Gonul AS, Cetinkalp S, Tunay S, Polat I, Simsek F, Aksoy B, Kizilates G, Erdogan Y, Coburn KL.
    J Psychiatr Res; 2017 Feb 15; 85():66-74. PubMed ID: 27837659
    [Abstract] [Full Text] [Related]

  • 19. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
    Petrowski K, Wintermann GB, Kirschbaum C, Bornstein SR.
    Psychoneuroendocrinology; 2012 Aug 15; 37(8):1199-208. PubMed ID: 22277728
    [Abstract] [Full Text] [Related]

  • 20. Suppressive effect of mirtazapine on the HPA system in acutely depressed women seems to be transient and not related to antidepressant action.
    Horstmann S, Dose T, Lucae S, Kloiber S, Menke A, Hennings J, Spieler D, Uhr M, Holsboer F, Ising M.
    Psychoneuroendocrinology; 2009 Feb 15; 34(2):238-248. PubMed ID: 18926641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.